A federal appeals court on Wednesday ruled against a lawsuit filed by representatives of the pharmaceutical industry challenging the federal Medicare drug price negotiation program, finding that drugmakers are not entitled to sell their products to Medicare at a price they would prefer. The U.S. Court of Appeals for the 5th Circuit affirmed a prior...
A federal appeals court on Wednesday ruled against a lawsuit filed by representatives of the pharmaceutical industry challenging the federal Medicare drug price negotiation program, finding that drugmakers are not entitled to sell their products to Medicare at a price they would prefer. The U.S. Court of Appeals for the 5th Circuit affirmed a prior...
<iframe src="https://statesidedaily.com/embed/cluster/935bdbaffa5177bd312c3cb579d95d40ebaee666" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Federal court rejects PhRMA challenge to Medicare drug price negotiation"></iframe>
